RBC Capital analyst Brandon Henry reiterated an Outperform rating and $65.00 price target on NuVasive (NASDAQ: NUVA) following SNN/Osiris deal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE